Identification of high-risk acute coronary syndromes by spectral analysis of ear photoplethysmographic waveform variability

被引:11
|
作者
Middleton, Paul M. [1 ,2 ,3 ]
Chan, Gregory S. H. [3 ]
Marr, Sebastian [2 ]
Celler, Branko G. [3 ]
Lovell, Nigel H. [3 ,4 ]
机构
[1] Ambulance Serv New S Wales, Ambulance Res Inst, Sydney, NSW 2039, Australia
[2] Prince Wales Hosp, Emergency Dept, Sydney, NSW 2031, Australia
[3] Univ New S Wales, Biomed Syst Lab, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia
[4] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia
基金
澳大利亚研究理事会;
关键词
cardiovascular variability; power spectrum analysis; coronary heart disease; autonomic nervous system; photoplethysmography; HEART-RATE-VARIABILITY; AUTONOMIC CONTROL; GLOBAL REGISTRY; PULSE OXIMETRY; MORTALITY; PRESSURE; ONSET;
D O I
10.1088/0967-3334/32/8/012
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
There is a need for robust techniques for early and accurate diagnosis of acute coronary syndromes (ACSs), to avoid inappropriate discharge of patients. This study examined the use of frequency spectrum analysis of heart rate variability (HRV) and photoplethysmogram (PPG) waveform variability for the identification of high-risk ACS patients defined by an elevated cardiac troponin level. The study cohort comprised a convenience sample of adult patients presenting to the emergency department of the Prince of Wales Hospital over a 4 month period complaining of non-traumatic chest pain. Valid electrocardiogram (ECG) and earlobe PPG waveforms together with troponin I test results were obtained from 52 patients at presentation, 4 of which were troponin I positive (Trop 0+). Frequency spectrum analysis was performed on the beat-to-beat HRV and PPG waveform variability (PPGV). The Trop 0+ were found to have significantly higher normalized mid-frequency power (MFnu) in HRV (P = 0.017), PPG amplitude variability (P = 0.009) and the cross-spectrum of HRV and PPGV (P = 0.001), which were attributed to reflex sympathetic response to myocardial ischemia. MFnu of PPG amplitude had the best overall performance in detecting Trop 0+, with ROC area under the curve of 0.93. The results demonstrate the potential use of ear PPG waveform to identify high-risk heart disease patients, and further highlight the utility of frequency spectrum analysis of PPGV in critical care.
引用
收藏
页码:1181 / 1192
页数:12
相关论文
共 50 条
  • [41] A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel plus aspirin versus aspirin alone
    Schleinitz, MD
    Heidenreich, PA
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 251 - 259
  • [42] Major bleeding is an independent predictor of short-term mortality in moderate and high-risk acute coronary syndromes: An analysis from the ACUITY trial
    Manoukian, Steven V.
    Feit, Frederick
    Mehran, Roxana
    Fazel, Reza
    Voeltz, Michele D.
    Dangas, George
    Ebrahimi, Ramin
    Hamon, Martial
    Pollack, Charles V., Jr.
    Hoekstra, James
    Lincoff, A. Michael
    King, Spencer B., III
    Ohman, E. Magnus
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 12B - 12B
  • [43] Acute coronary syndromes without chest pain: a high risk group?
    Magalhaes, P.
    Leao, S.
    Cordeiro, F.
    Mateus, P.
    Carvalho, S.
    Moreira, J. I.
    EUROPEAN HEART JOURNAL, 2015, 36 : 583 - 584
  • [44] Acute coronary syndromes without chest pain: a high risk group?
    Pedro Magalhaes, P.
    Leao, S.
    Cordeiro, F.
    Mateus, P.
    Carvalho, S.
    Moreira, J. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 365 - 365
  • [45] Acute coronary syndrome as the index presentation of a high-risk congenital coronary anomaly
    Gonzales, David Chipayo
    Perez-Espejo, Paloma
    Shabbir, Asad
    Silva-Cerpa, Miguel Angel
    Fernandez, Javier Portales
    CORONARY ARTERY DISEASE, 2023, 34 (01) : 84 - 85
  • [46] An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease
    Medi, C.
    Chew, D. P. B.
    Amerena, J.
    Coverdale, S.
    Soman, A.
    Astley, C.
    Rankin, J.
    Brieger, D.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (10) : 743 - 750
  • [47] Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade
    Newby, LK
    Christenson, RH
    Ohman, EM
    Armstrong, PW
    Harrington, RA
    White, HD
    Irl, C
    Califf, RM
    Topol, EJ
    CIRCULATION, 2000, 102 (18) : 589 - 589
  • [48] Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial
    Kenneth W. Mahaffey
    Qinghong Yang
    Karen S. Pieper
    Elliott M. Antman
    Harvey D. White
    Shaun G. Goodman
    Marc Cohen
    Neal S. Kleiman
    Anatoly Langer
    Philip E. Aylward
    Jacques J. Col
    Craig Reist
    James J. Ferguson
    Robert M. Califf
    Journal of General Internal Medicine, 2008, 23 : 310 - 316
  • [49] Prediction of one-year survival in high-risk patients with acute coronary syndromes: Results from the SYNERGY trial
    Mahaffey, Kenneth W.
    Yang, Qinghong
    Pieper, Karen S.
    Antman, Elliott M.
    White, Harvey D.
    Goodman, Shaun G.
    Cohen, Marc
    Kleiman, Neal S.
    Langer, Anatoly
    Aylward, Philip E.
    Col, Jacques J.
    Reist, Craig
    Ferguson, James J.
    Califf, Robert M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (03) : 310 - 316
  • [50] The incidence and outcomes of high-risk acute coronary syndromes in Western Cape Province, South Africa: A prospective cohort study
    Cilliers, J. D.
    Joubert, L.
    Beyers, B.
    Ngarande, E.
    Herbst, P.
    Doubell, A.
    Pecoraro, A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2023, 113 (05): : 1199 - 1203